Print Services: Subscribe | Home Delivery Web: Mobile Edition |

Site Web Search powered by YAHOO!SEARCH
By: Benzinga
UPDATE: Bloom Burton Downgrades YM BioSciences to Hold Post Gilead Acquisition
Bloom Burton lowered its rating on YM BioSciences (NYSE: YMI ) from Buy to Hold with a $2.95 price target. Bloom Burton noted, "We are updating our price target to US$2.95 and rating to Hold after last week's announcement of the acquisition of YM by Gilead Sciences (NASDAQ:
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here